Amnesia

Government of Canada invests in developing a portable test for domoic acid, a marine biotoxin

Retrieved on: 
Wednesday, January 10, 2024
Shellfish, Economic development, Food safety, CFIA, Nanoparticle, Research, Government, ISC, Animal, Agency, Knowledge, Canadian Food Inspection Agency, Poisoning, Ecosystem, Environment, Climate change, Water, The Honourable, DSM-IV codes, Organization, Amnesia, Plant, Seafood, Government of Canada, Growth, Aquaculture

This and other marine biotoxins are of particular interest to communities with a greater reliance on fish and seafood in their diets.

Key Points: 
  • This and other marine biotoxins are of particular interest to communities with a greater reliance on fish and seafood in their diets.
  • Eating shellfish with high levels of marine biotoxins, including domoic acid, can cause severe food poisoning and life-threatening neurological effects.
  • This type of portable test would be used to detect even the lowest levels of domoic acid in marine waters in real time.
  • Research and development on a portable test for domoic acid can help advance our understanding of the relationship between this marine biotoxin and environmental conditions."

Human medicines European public assessment report (EPAR): Vizamyl, flutemetamol (18F), Date of authorisation: 22/08/2014, Revision: 17, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Blood pressure, Amnesia, Patient, Medical Subject Headings, Autopsy, Marketing, European Commission, Dementia, Agency, INN, Risk, Physician, ATC, Positron emission tomography, International, European, PET, Nausea, Nuclear medicine, Brain, Language, Gelastic seizure, Cancer, Flushing, Chronic pain, Radiation, Lewy body dementias, Amyloid, Select, Committee, Medicine, Diagnosis, Safety, Radiopharmaceutical, Risk management, Anatomy, Skin, IIA, Deficit spending, CHMP, Medical imaging

Human medicines European public assessment report (EPAR): Vizamyl, flutemetamol (18F), Date of authorisation: 22/08/2014, Revision: 17, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Vizamyl, flutemetamol (18F), Date of authorisation: 22/08/2014, Revision: 17, Status: Authorised

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

Retrieved on: 
Wednesday, December 6, 2023
Obstructive sleep apnea, Deficit spending, Depression, Disease, Ageing, Blood, Claustrophobia, Accident, Dronabinol, Death, Workplace, Metabolic acidosis, Noise, Conditional sentence, Sleep, Amnesia, Patient, Diagnosis, Cardiovascular disease, PAP, Safety, CO2, AHI, PSG, Somnolence, Acetazolamide, Polysomnography, Judgement, Pharmaceutical industry

Obstructive sleep apnea (OSA) is characterised by a narrowing or obstruction of the upper airway during sleep, which interrupts breathing resulting in decreased oxygen uptake and poor sleep quality.

Key Points: 
  • Obstructive sleep apnea (OSA) is characterised by a narrowing or obstruction of the upper airway during sleep, which interrupts breathing resulting in decreased oxygen uptake and poor sleep quality.
  • Incannex has designed IHL-42X, a combination of dronabinol (synthetic THC) and acetazolamide, for treatment of OSA.
  • A video presentation of IHL-42X for the treatment of OSA has been uploaded to the Incannex website, link here: https://www.incannex.com/clinical-trail/ihl-42x-osa/ .
  • This gave Incannex the confidence to proceed with a multisite Phase 2/3 clinical trial further investigating safety and efficacy of IHL-42X in patients with OSA.

Silverado Memory Care Experts Share Insights for the Holiday Season

Retrieved on: 
Tuesday, December 12, 2023
Mental Health, Nursing, Seniors, Neurology, Practice Management, Managed Care, Health, Consumer, General Health, Holiday, Photography, Anecdote, Brain, Behavior, Hobby, Senior, Love, Depression, Cooking, RN, GNP, Friends, Dementia, Personality, Quality of life, Confusion, Environment, Amnesia, Proxemics, Tourism

As friends and families prepare to spend time together during the holiday season, Silverado Memory Care , a recognized expert in the memory care field, released tips today for recognizing memory loss in a loved one.

Key Points: 
  • As friends and families prepare to spend time together during the holiday season, Silverado Memory Care , a recognized expert in the memory care field, released tips today for recognizing memory loss in a loved one.
  • The most common signs that dementia-related changes may be taking place in the brain include:
    Forgetting new information and important dates or events.
  • Difficulties during conversations — repetition, losing their thought, not finding the right word or using an incorrect one.
  • During the holidays, it is key to help loved ones experiencing memory loss connect to the joy they felt this time of year.

New Indie World Showcase Uncorks the Bottle on More Than a Dozen Upcoming Nintendo Switch Games

Retrieved on: 
Tuesday, November 14, 2023
Electronic Games, Entertainment, Mobius, EOS, Online, Weapon, Sound, Echoes, Different, News, Heavenly Bodies, Mechanics, Howl, Indie, Multimedia, Friends, Photography, Internet access, Annapurna Interactive, Braid, Diner, Love, Nintendo Switch, Snow, Galaxy, Nintendo eShop, Stars named after people, My 60 Memorable Games, Solar System, Amnesia, Outer Wilds, Sand, PLAYISM, Highlands (song), Lumina, Dungeon, Eye, Nintendo Direct, Rain, Nintendo Switch Online, Planet, Shantae: Half-Genie Hero, Core Keeper, WayForward, Video game, Inkle, Nintendo, Shantae, Chimera

In the latest Indie World showcase , Nintendo presented an exciting lineup of indie games that will be arriving to the Nintendo Switch family of systems in 2023 and beyond.

Key Points: 
  • In the latest Indie World showcase , Nintendo presented an exciting lineup of indie games that will be arriving to the Nintendo Switch family of systems in 2023 and beyond.
  • View the full release here: https://www.businesswire.com/news/home/20231114920688/en/
    Shantae Advance: Risky Revolution launches for Nintendo Switch in 2024.
  • For the latest news and updates about indie games on Nintendo Switch, follow the Indie World X account @IndieWorldNA and check out https://www.nintendo.com/us/indie-world/news/ .
  • * Any Nintendo Switch Online membership (sold separately) and Nintendo Account required for online features.

Start a New Winter Tradition with WinterFaire Make Lasting Memories in A New Magical Winter Wonderland

Retrieved on: 
Monday, December 11, 2023
Storm, Browne's Addition, Spokane, Flip, Life, Llama, Heritage, Pajamas, LLP, Children, Energy, Gertie the Dinosaur, The Children's Museum, Ice, Delta Dental, Old National Bank, System, Friends, Amnesia, Museum, Lilly, Family, Magical, Cherokee heritage groups, Amusement park, Toy, Communications satellite, Tourism, Workshop, Indigo, Manor

INDIANAPOLIS, Dec. 11, 2023 /PRNewswire-PRWeb/ -- Experience a brand-new magical indoor winter wonderland called WinterFaire at the world's largest children's museum. It is sure to become a new tradition for all this season. Visitors can expect to see a festive, carnival-like atmosphere complete with fun games, hands-on activities, adorable animal characters, special visits with Santa and sliding down the iconic 47-foot-long Winter Slide.

Key Points: 
  • Experience the joy and wonder of WinterFaire, an enchanting winter wonderland hosted at The Children's Museum of Indianapolis.
  • INDIANAPOLIS, Dec. 11, 2023 /PRNewswire-PRWeb/ -- Experience a brand-new magical indoor winter wonderland called WinterFaire at the world's largest children's museum.
  • A magical winter wonderland brings woodland characters to life as children and their grownups play skee ball and hit virtual targets with snowballs to create new family members.
  • In the center of the space, visitors will find Indigo, a mystical and knowledgeable chameleon perched on a magical fountain.

CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

Retrieved on: 
Friday, December 8, 2023
Hong Kong, Brain, Lancet Group of Laboratories, CUHK Faculty of Medicine, Urinary tract infection, Risk, Clinical trial, Fatigue, CUHK, Government, Patient, Research, Infection, Medicine, COVID-19, Growth, Microbiota, Health, Amnesia, COVID, Pharmaceutical industry, Magic

The study has profound implications for the role of gut microbiota modulation in improving symptoms in subjects with long COVID.

Key Points: 
  • The study has profound implications for the role of gut microbiota modulation in improving symptoms in subjects with long COVID.
  • The landmark findings have recently been published in The Lancet Infectious Disease, a publication from The Lancet Group.
  • Long COVID refers to long-term symptoms involving multiple systems and organs that persist in recovered COVID-19 patients.
  • The research team has previously shown that patients with long COVID lacked a series of beneficial gut bacteria, which may contribute to multiple symptoms.

CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

Retrieved on: 
Friday, December 8, 2023
Hong Kong, Brain, Lancet Group of Laboratories, CUHK Faculty of Medicine, Urinary tract infection, Risk, Clinical trial, Fatigue, CUHK, Government, Patient, Research, Infection, Medicine, COVID-19, Growth, Microbiota, Health, Amnesia, COVID, Pharmaceutical industry, Magic

The study has profound implications for the role of gut microbiota modulation in improving symptoms in subjects with long COVID.

Key Points: 
  • The study has profound implications for the role of gut microbiota modulation in improving symptoms in subjects with long COVID.
  • The landmark findings have recently been published in The Lancet Infectious Disease, a publication from The Lancet Group.
  • Long COVID refers to long-term symptoms involving multiple systems and organs that persist in recovered COVID-19 patients.
  • The research team has previously shown that patients with long COVID lacked a series of beneficial gut bacteria, which may contribute to multiple symptoms.

Houston Internist and Artist, Cynthia Williams, MD Donates 100% of Art Sale Proceeds Through January 2024 to Houston Nonprofit Care Partners--Dementia Care Division

Retrieved on: 
Tuesday, November 28, 2023
Alzheimer's disease, Brain, CCP, Language, Patient, Animal, Farm, Caregiver, Emotion, Garden, Dementia, MD, Speech, Happiness, Amnesia, Education, Residential care

HOUSTON, Nov. 28, 2023 /PRNewswire/ -- Concierge Choice Physicians (CCP), the nation's leading full-service concierge medical service provider, proudly announces their client, local physician and artist Cynthia Williams, MD, is raising money to support seniors, older people in care facilities and those suffering from dementia by donating 100% of the proceeds from her art sales to Care Partners Texas. This fundraising effort is currently in place through the end of January 2024.

Key Points: 
  • According to Alzheimer's and dementia experts, art therapy—particularly painting—is an excellent way to connect with seniors who may be experiencing problems with speech and language.
  • "The joy I see on the faces of older patients who can suddenly explore with color and paint their emotions is inspiring.
  • Dr. Williams has a unique dimensional and vibrant style of painting which make her art lovely holiday gifts.
  • Once again, 100% of all proceeds go to benefit Care Partners -Dementia Care, a nationally recognized nonprofit organization providing high-quality care for older adults and people with dementia, as well as their caregivers across Greater Houston.

uMETHOD Health Highlights Factors Contributing to Cognitive Decline for Alzheimer's Awareness Month

Retrieved on: 
Wednesday, November 1, 2023
Alzheimer's disease, Education, Physician, APOE4, National Stroke Awareness Month, Conditional sentence, Amnesia, Health, Atmosphere, Dementia, Research, HIV disease progression rates, Disease, Risk, Myenteric plexus, Medicine, Confusion, Kidney disease, Water, Brain, Pain, Patient, Pharmaceutical industry, Nursing, Medical imaging

RALEIGH, N.C., Nov. 1, 2023 /PRNewswire/ -- uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, is taking an active role in drawing attention to the various factors that can contribute to the development of Alzheimer's disease. As a part of its efforts during Alzheimer's Awareness Month, uMETHOD is educating the public on the risk factors associated with Alzheimer's and the importance of early intervention.

Key Points: 
  • As a part of its efforts during Alzheimer's Awareness Month, uMETHOD is educating the public on the risk factors associated with Alzheimer's and the importance of early intervention.
  • Alzheimer's disease is a progressive brain disorder that affects 5.7 million U.S. adults, with many more in preceding stages of decline.
  • Through RestoreU , uMETHOD harnesses the power of analytics and data to help physicians close care gaps for patients with cognitive decline.
  • Join us on Facebook , Twitter and LinkedIn this month as we share more information about these contributing factors and how to boost your brain health.